UNSPSC 51184000: Antidiabetic and hyperglycemic sulfonylureas

This classification denotes substances composed of substituted arylsulfonylureas that lower blood glucose levels by increasing pancreatic insulin release, thus the term ANTIDIABETIC AND HYPERGLYCEMIC SULFONYLUREAS.

UNSPSC 51184000 Antidiabetic and hyperglycemic sulfonylureas is a Class code encompassing generic pharmaceutical products used to manage diabetes and blood-sugar regulation, as procured through state and local cooperative purchasing agreements. State and local governments acquire these medications through multistate cooperative purchasing vehicles to distribute across public healthcare facilities, correctional institutions, and social-service agencies. The work involves manufacturers supplying products with specific National Drug Codes (NDC), SKUs, UPCs, and packaging configurations through authorized pharmaceutical wholesalers, with vendors certifying compliance with current Good Manufacturing Practices (cGMP), the Drug Supply Chain Security Act (DSCSA), and FDA requirements. Issuing bodies include state departments of administration and multistate purchasing alliances that aggregate demand across participating jurisdictions. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, is a primary vehicle for this category of procurement.

The code shows recent activity centered in the Upper Midwest and Pacific Northwest. MMCAP's January 2026 RFP for Generic Multi Source Pharmaceuticals and OTC Products, with a response deadline of March 26, 2026, represents the most visible current opportunity under this class; the procurement establishes multiple awards across participating states including Minnesota and Oregon, with resulting contracts effective July 1, 2026. Vendors must maintain relationships with at least two of three authorized wholesalers (AmerisourceBergen Drug Corporation/Cencora, Cardinal Health 110 and 112, and Morris & Dickson Co., LLC), demonstrate pricing flexibility through flat price, net price (NF30, NF60, NF90), or WAC-minus formats, and carry commercial general liability of $5,000,000 per occurrence and network security and privacy liability of $2,000,000. The contract term is two years for new responders with optional extensions at MMCAP's discretion, while incumbent vendors' amendments extend through June 30, 2028. Award decisions are weighted on price competitiveness (75 percent), with the remainder distributed across fixed pricing, administrative-fee compliance, EDI capability, and pricing-format agreement.